Exclusive

Publication

Byline

Location

Clinical Trial: Mechanistic Investigation of CD2AP-Mediated Extracellular Vesicle Biogenesis via Liquid–Liquid Phase Separation in Primary Nephrotic Syndrome: Implications for Podocyte–Parietal Epithelial Cell Crosstalk (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanistic Investigation of CD2AP-Mediated Extracellular Vesicle Biogenesis via Liquid... Read More


Clinical Trial: A multicenter, randomized, double-blind, parallel-controlled, dose-range Phase II clinical study to evaluate the efficacy and safety of VB19055 in participants with uncontrolled hypertension (including refractory hypertension) after treatment with two or more antihypertensive drugs (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, double-blind, parallel-controlled, dose-range Phase II clini... Read More


Clinical Trial: Research on the Neural Mechanisms of Discourse Production in Aphasia Patients: Based on the Mandarin Aphasia Corpus and Near-Infrared Brain Imaging (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Neural Mechanisms of Discourse Production in Aphasia Patients: Based on... Read More


Clinical Trial: A New Rehabilitation Method for Adolescent Scoliosis Combining Unilateral Lower Limb Strengthening Training and Schroth Therapy (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A New Rehabilitation Method for Adolescent Scoliosis Combining Unilateral Lower Limb St... Read More


Clinical Trial: Efficacy and Safety of 0.01% Atropine Eye Drops in Delaying the Progression of Moderate to High Myopia in Children and Adolescents. (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of 0.01% Atropine Eye Drops in Delaying the Progression of Moderate... Read More


Clinical Trial: Baveno VII criteria-guided initiation of non-selective beta blocker in patients with compensated advanced chronic liver disease to reduce hepatic decompensation: an open-label randomised controlled trial (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Baveno VII criteria-guided initiation of non-selective beta blocker in patients with co... Read More


Clinical Trial: A Study of Inflammatory Markers in Blood, Bronchoalveolar Lavage Fluid, and Urine of Patients with Sepsis (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of Inflammatory Markers in Blood, Bronchoalveolar Lavage Fluid, and Urine of Pa... Read More


Clinical Trial: The accuracy evaluation of registration template for jaw relation registration in immediate full-arch implant rehabilitation (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The accuracy evaluation of registration template for jaw relation registration in immed... Read More


Clinical Trial: Screening of Predictive Biomarkers for Therapeutic Efficacy and Research on Drug Resistance Mechanisms of IL-17A Inhibitors in the Treatment of Hidradenitis Suppurativa (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening of Predictive Biomarkers for Therapeutic Efficacy and Research on Drug Resist... Read More


Clinical Trial: The Effect of rPMS Stimulation at Lianquan (CV23) Acupoint on Swallowing Function in Post-Stroke Dysphagia Patients and Its Underlying Neural Mechanisms (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effect of rPMS Stimulation at Lianquan (CV23) Acupoint on Swallowing Function in Po... Read More